While the EU Commission seeks to reduce strategic dependencies, Europe continues to import nearly a third of its blood plasma ...

A study by researchers at the Interuniversity Institute of Bioinformatics in Brussels, the Structural Biology research group ...

FDA approves first blood test for Alzheimer's detection. Simple blood draw replaces expensive scans and spinal taps.

Participants in the highest BGAT quartile of this study had a hazard ratio for VTE risk of 2.12 compared with those in the lowest BGAT quartile after adjusting for age and sex characteristics.

Children born before 37 weeks of gestation have a considerably increased risk of dying before they reach the age of five.

The FDA has granted 510(k) marketing clearance to the first in vitro blood-based biomarker diagnostic device for Alzheimer’s ...

Researchers evaluated a fully automated plasma biomarker panel to detect early amyloid-β accumulation in cognitively ...

The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps ...

The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by ...

The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in ...

New blood test approved for Alzheimer's diagnosis. The test measures two proteins in blood plasma, correlating with amyloid plaques in the brain.